While new best-in-class drugs are available privately immediately, EMA(European Medicines Agency) approval is only the first step in getting such treatments through the public drug reimbursement process. The pharmaceutical companies must approach EU health services separately for assessment even after EMA approval.
While new best-in-class drugs are available privately immediately, EMA approval is only the first step in getting such treatments through the public drug reimbursement process. The pharmaceutical companies must approach EU health services separately for assessment even after EMA approval.
“As things stand right now, if the EMA approves something today, then tomorrow the private patient will be able to access it — but for the public patient, it might take two years,” Dr McCarthy said.
Some 55% of adults in Ireland do not have health insurance, according to the latest figures.
Lynch Syndrome Ireland 